U.S. gives green light to publish controversial bird flu research

April 23, 2012
U.S. gives green light to publish controversial bird flu research
After expert panel review, officials say H5N1 findings are of benefit, with little risk to national security.

(HealthDay) -- The U.S. government is giving the go-ahead for publication of two controversial studies into the H5N1 avian (bird) flu virus, a top federal health official announced Friday.

The research, led by two scientists -- Yoshihiro Kawaoka of the University of Wisconsin and Ron Fouchier of Erasmus Medical Center in Rotterdam, the Netherlands -- involved the manipulation of the potentially until it was transmissible between ferrets, thought to be a close model for humans. As yet, is not easily transmitted between humans.

In December, the Department of Health and Human Services (HHS) requested that two leading journals, Science and Nature, censor some of the data from this research for national security reasons. The concern was that terrorists might use the information to create a biological weapon.

However, on Friday, Dr. Francis Collins, director of the U.S. National Institutes of Health, announced in a statement that full publication could go forward. The decision was based on a March 29-30 meeting of the National Science Advisory Board for (NSABB), an independent panel of experts that advises the federal government on such matters.

According to Collins, "After careful deliberation, the NSABB unanimously recommended the revised manuscript by Dr. Yoshihiro Kawaoka be communicated in full. The NSABB also recommended, in a 12-to-6 decision, that the data, methods, and conclusions presented in the revised manuscript by Dr. Ron Fouchier be communicated fully after a number of further scientific clarifications are made in the manuscript."

Collins added that the research has "direct applicability to ongoing and future efforts and does not appear to enable direct misuse of the research in ways that would endanger public health or national security."

He said that HHS Secretary agreed with the decision. "The information in the two manuscripts should be communicated fully and we have conveyed our concurrence to the journals considering publication of the manuscripts," Collins said.

Kathy Wren, a spokeswoman for Science, which is withholding the Fouchier study, said the journal is still waiting for a decision by Dutch regulators next week before deciding when it will publish the research, Bloomberg News reported.

Explore further: Mutant bird flu 'less lethal', says paper's author

More information: Find out more about H5N1 avian influenza at the U.S. Centers for Disease Control and Prevention.

Related Stories

Mutant bird flu 'less lethal', says paper's author

April 3, 2012
The author of a paper on a mutant bird flu strain said Monday that experts agreed to publish it only after he explained that the virus was "much less lethal" than previously feared.

Go-ahead for bird flu study publication after security check (Update)

February 17, 2012
Bird flu experts meeting in Geneva on Friday ruled that controversial research on a mutant form of the virus potentially capable of being spread among humans should be made public.

Divides emerge in US, world response to mutant flu

February 29, 2012
A divide has emerged between the United States and the rest of the world on whether to publish or keep secret the details of an engineered mutant bird flu virus that can pass in the air between animals, health experts said ...

Recommended for you

How defeating THOR could bring a hammer down on cancer

December 14, 2017
It turns out Thor, the Norse god of thunder and the Marvel superhero, has special powers when it comes to cancer too.

Researchers track muscle stem cell dynamics in response to injury and aging

December 14, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP) describes the biology behind why muscle stem cells respond differently to aging or injury. The findings, published in Cell Stem Cell, ...

'Human chronobiome' study informs timing of drug delivery, precision medicine approaches

December 13, 2017
Symptoms and efficacy of medications—and indeed, many aspects of the human body itself—vary by time of day. Physicians tell patients to take their statins at bedtime because the related liver enzymes are more active during ...

Estrogen discovery could shed new light on fertility problems

December 12, 2017
Estrogen produced in the brain is necessary for ovulation in monkeys, according to researchers at the University of Wisconsin-Madison who have upended the traditional understanding of the hormonal cascade that leads to release ...

Time of day affects severity of autoimmune disease

December 12, 2017
Insights into how the body clock and time of day influence immune responses are revealed today in a study published in leading international journal Nature Communications. Understanding the effect of the interplay between ...

3-D printed microfibers could provide structure for artificially grown body parts

December 12, 2017
Much as a frame provides structural support for a house and the chassis provides strength and shape for a car, a team of Penn State engineers believe they have a way to create the structural framework for growing living tissue ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.